NIDA Research Monograph, Number 175 [Printed in 1998]
If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able
to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.
To download all of the PDF documents in an archive format, choose the
type you wish to download, decompress the file with the decompression software
on your computer, then view using Adobe
Acrobat Reader.
Macintosh - Monograph175.hqx
(3.1 MB)
Windows 3.1/95/NT - MONOG175.ZIP
(2.2 MB)
Click on link to go page
Table of Contents
Preface-----1
Betty Tai, Charles V. Grudzinskas, Nora Chiang, and
Peter Bridge
Goals and Rationale for Pharmacotherapeutic Approach in Treating Cocaine Dependence: Insights From Basic and
Clinical Research-----5
Mary Jeanne Kreek
Overview of Potential Treatment Medications for Cocaine
Dependence-----36
Elinore F. McCance
Methodologic Recommendations for Cocaine Abuse Clinical
Trials: A Clinician-Researcher's Perspective-----73
Edward V. Nunes
Management of Clinical Trials With New Medications for
Cocaine Dependence and Abuse-----96
Ari Kiev
Outcome Measurement Considerations: Pharmacological
Treatments for Substance Abuse-----118
Karla Moras
Variability in Treatment-Seeking Cocaine Abusers: Implications
for Clinical Pharmacotherapy Trials-----137
Kathleen M. Carroll, Charla Nich, and Bruce J. Rounsaville
Baseline Assessment, Study Entry, and Stabilization:
Double-Blind Clinical Trials in Drug Dependence-----158
John Grabowski, Gila Arnoni, Ronith Elk, Howard Rhoades,
and Joy Schmitz
The Addiction Severity Index in Clinical Efficacy Trials of
Medications for Cocaine Dependence-----182
John S. Cacciola, Arthur I. Alterman, Charles P. O'Brien,
and A. Thomas McLellan
Cognitive-Neuromotor Assessment of Substance Abuse:
Focus on Issues Related to Cocaine Abuse Treatment-----192
E.H. Ellinwood, Jr. and T.H. Lee
Treatment Effectiveness Score as an Outcome Measure in
Clinical Trials-----208
Walter Ling, Steven Shoptaw, Donald Wesson, Richard A.
Rawson, Margaret Compton, and C. James Klett
Pharmacokinetics of Cocaine: Considerations When Assessing
Cocaine Use by Urinalysis-----221
Reese T. Jones
Quantitative Urine Levels of Cocaine and Other Substances of Abuse-----235
Jeffery N. Wilkins
Use of Quantitative Urinalysis in Monitoring Cocaine Use-----253
Kenzie L. Preston, Kenneth Silverman, Charles R. Schuster,
and Edward J. Cone
Is Quantitative Urinalysis More Sensitive?-----265
Shou-Hua Li, Nora Chiang, Betty Tai, Charles K.
Marschke, and Richard L. Hawks
Comparison of Immunoassays for Semiquantitative Measurement
of Benzoylecgonine in Urine-----287
Rodger L. Foltz, Christine Botelho, Scott A. Reuschel,
David J. Kuntz, David E. Moody, and Gloria M. Bristow
TAppendix I: Workshop Summary Outcome Measures and
Success Criteria-----303
Betty Tai
Appendix II: Workshop Summary Clinical Decision Tree for
Cocaine Addiction Pharmacotherapy-----312
Betty Tai, Charles V. Grudzinskas, Peter Bridge, and
Nora Chiang
Ordering Information-----318
|